製品の概要

  • 製品名AM251
  • 製品の詳細
    CB1 receptor antagonist / inverse agonist
  • 生理活性の詳細Cannabinoid CB1 receptor antagonist / inverse agonist (Ki = 7.5 nM). Displays 306-fold selectivity over CB2 receptors. Anorectic and antidepressant in vivo.
  • 精製度> 99%

製品の特性

    AM251 (ab120088) 使用論文

    This product has been referenced in:
    • Shearman LP  et al. Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice. Behav Pharmacol 14:573-82 (2003). Read more (PubMed: 14665974) »
    • Lan R  et al. Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. J Med Chem 42:769-76 (1999). Read more (PubMed: 10052983) »
    • Gatley SJ  et al. Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors. Life Sci 61:PL 191-7 (1997). Read more (PubMed: 9335234) »

    See all 13 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120088.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"